中草药

肠道微生态视角下探讨中药调控嗜黏蛋白阿克曼菌改善炎症性肠病机制

PDF下载

中草药 | 综述 2026,57(18): 7462-7475

收起

中草药 |综述 2026 , 57 (18) : 7462 -7475

肠道微生态视角下探讨中药调控嗜黏蛋白阿克曼菌改善炎症性肠病机制

全屏

朱凡¹, 胡晓妹¹, 梁琪¹, 朱芸¹, 彭博¹, 李正韦², 张武剑³, 李桃^1,4

作者信息

通讯作者:

李桃

作者简介:

朱凡: 朱凡，硕士研究生，研究方向为康复治疗。E-mail:zhufantmu@163.com

Mechanism of traditional Chinese medicine regulating Akkermansia muciniphila to improve inflammatory bowel disease from perspective of gut microecology

ZHU Fan¹, HU Xiaomei¹, LIANG Qi¹, ZHU Yun¹, PENG Bo¹, LI Zhengwei², ZHANG Wujian³, LI Tao^1,4

Affiliations

doi: 10.7501/j.issn.0253-2670.2026.18.032

文章导航

摘要

收起

嗜黏蛋白阿克曼菌（Akkermansia muciniphila，AKK）是定植于肠道黏液层的重要共生菌，在维持肠道屏障完整性、调节免疫稳态及参与代谢调控等方面发挥关键作用。近年来研究表明，炎症性肠病（inflammatory bowel disease，IBD）患者肠道内AKK丰度显著降低，其动态变化与疾病活动度密切相关。动物实验显示，补充该菌或其功能蛋白可通过调控“肠屏障-免疫炎症-代谢”三重通路缓解肠道炎症。然而，在特定病理状态下，AKK亦可能通过过度降解黏液层而加重屏障损伤，提示其具有显著的情境依赖性双向调控特征。中药及其活性成分可通过直接提供营养底物、促进黏液分泌、重塑菌群结构及调节代谢互作等多途径，双向调控AKK丰度与功能，从而维持肠道微生态稳态并发挥抗IBD作用。系统综述AKK在IBD中的双重作用机制及其在肠屏障修复、免疫调控和代谢重塑中的作用，并重点总结中药通过靶向AKK介导“菌群-屏障-免疫”轴改善IBD的研究进展，以期为基于关键菌调控的中药微生态干预策略提供理论依据与研究方向。

关键词

嗜黏蛋白阿克曼菌 / 炎症性肠病 / 溃疡性结肠炎 / 中药 / 肠道菌群

Abstract

收起

Akkermansia muciniphila (AKK) is a key commensal bacterium colonizing the intestinal mucus layer, playing a crucial role in maintaining intestinal barrier integrity, regulating immune homeostasis and participating in metabolic control. Recent studies indicate that the abundance of AKK is significantly reduced in the intestines of patients with inflammatory bowel disease (IBD), with its dynamic changes closely correlated with disease activity. Animal experiments demonstrate that supplementing this bacterium or its functional proteins can alleviate intestinal inflammation by regulating the “intestinal barrier-immune inflammation-metabolism” triple pathway. However, under specific pathological conditions, AKK may also exacerbate barrier damage by excessively degrading the mucus layer, suggesting that they exhibit significant context-dependent bidirectional regulatory characteristics. Traditional Chinese medicine (TCM) and its active components can bidirectionally regulate the abundance and function of AKK through multiple pathways, including the direct supply of nutritional substrates, promotion of mucus secretion, remodeling of the microbial community structure and regulation of metabolic interactions, thereby maintaining the homeostasis of the gut microbiome and exerting an anti-IBD effect. This article systematically reviews the dual mechanisms of action of AKK in IBD and their roles in intestinal barrier repair, immune regulation and metabolic remodeling. It focuses on summarizing research progress of TCM in improving IBD by targeting the AKK-mediated “microbiota-barrier-immunity” axis, with the aim of providing a theoretical basis and research directions for TCM microbiota intervention strategies based on the regulation of key bacteria.

Key words

Akkermansia muciniphila / inflammatory bowel disease / ulcerative colitis / traditional Chinese medicine / gut microbiota

引用本文

朱凡, 胡晓妹, 梁琪, 朱芸, 彭博, 李正韦, 张武剑, 李桃. 肠道微生态视角下探讨中药调控嗜黏蛋白阿克曼菌改善炎症性肠病机制. 中草药, 2026 , 57 (18) : 7462 -7475 . DOI: 10.7501/j.issn.0253-2670.2026.18.032

ZHU Fan, HU Xiaomei, LIANG Qi, ZHU Yun, PENG Bo, LI Zhengwei, ZHANG Wujian, LI Tao. Mechanism of traditional Chinese medicine regulating Akkermansia muciniphila to improve inflammatory bowel disease from perspective of gut microecology[J]. Chinese Traditional and Herbal Drugs, 2026 , 57 (18) : 7462 -7475 . DOI: 10.7501/j.issn.0253-2670.2026.18.032

基金

收起

黑龙江省自然科学基金项目 (PL2024H207); 湖南省自然科学基金项目 (2026JJ60391)

参考文献

收起

文献

收起

参考文献引证文献

排序方式：

Iliev I D, Ananthakrishnan A N, Guo C J. Microbiota in inflammatory bowel disease:Mechanisms of disease and therapeutic opportunities[J]. Nat Rev Microbiol, 2025,23(8):509-524.
彭衡英,刘吉华.肠道菌群在炎症性肠病发病机制与治疗中的作用研究进展[J]. 药学进展, 2021, 45(8):627-636.
Cani P D, Depommier C, Derrien M, et al. Akkermansia muciniphila:Paradigm for next-generation beneficial microorganisms[J]. Nat Rev Gastroenterol Hepatol, 2022,19(10):625-637.
Zheng M Y, Han R, Yuan Y L, et al. The role of Akkermansia muciniphila in inflammatory bowel disease:Current knowledge and perspectives[J]. Front Immunol,2023, 13:1089600.
Li J J, Zhang L, Li Y F, et al. Puerarin improves intestinal barrier function through enhancing goblet cells and mucus barrier[J]. J Funct Foods, 2020, 75:104246.
Tao Q, Liang Q, Fu Y, et al. Puerarin ameliorates colitis by direct suppression of macrophage M1 polarization in DSS mice[J]. Phytomedicine, 2024, 135:156048.
孟欢,侯晓婷,张华敏,等.中药天然产物治疗炎症性肠病的研究进展[J]. 中草药, 2023, 54(10):3349-3369.
张树辉,部繁,段正兰,等.中药促进AKK功能发挥的研究进展[J]. 中医药信息, 2020, 37(6):118-123.
Cai Y J, Li X, Han Q, et al. Si-Ni-San improves experimental colitis by favoring Akkermensia colonization[J]. J Ethnopharmacol, 2023, 305:116067.
黄钲淇,姬永宽,陈国森,等.慢溃宁方对溃疡性结肠炎小鼠炎症因子表达及肠道菌群的影响[J]. 中国实验方剂学杂志, 2022, 28(12):86-95.
Wang Y M, Li C X, Li J P, et al. Abelmoschus manihot polysaccharide fortifies intestinal mucus barrier to alleviate intestinal inflammation by modulating Akkermansia muciniphila abundance[J]. Acta Pharm Sin B, 2024, 14(9):3901-3915.
Zhang H R, Zhuo S X, Song D N, et al. Icariin inhibits intestinal inflammation of DSS-induced colitis mice through modulating intestinal flora abundance and modulating p-p65/p65 molecule[J]. Turk J Gastroenterol,2021, 32(4):382-392.
Zhao S S, Xiang J, Abedin M, et al. Characterization and anti-inflammatory effects of Akkermansia muciniphiladerived extracellular vesicles[J]. Microorganisms, 2025,13(2):464.
Earley H, Lennon G, BalfeÁ, et al. The abundance of Akkermansia muciniphila and its relationship with sulphated colonic mucins in health and ulcerative colitis[J]. Sci Rep, 2019, 9(1):15683.
Gaifem J, Mendes-Frias A, Wolter M, et al. Akkermansia muciniphila and Parabacteroides distasonis synergistically protect from colitis by promoting ILC3 in the gut[J]. m Bio, 2024, 15(4):e00078-e00024.
Zhai R, Xue X H, Zhang L Y, et al. Strain-specific antiinflammatory properties of two Akkermansia muciniphila strains on chronic colitis in mice[J]. Front Cell Infect Microbiol, 2019, 9:239.
Bian X Y, Wu W R, Yang L Y, et al. Administration of Akkermansia muciniphila ameliorates dextran sulfate sodium-induced ulcerative colitis in mice[J]. Front Microbiol, 2019, 10:2259.
Ottman N, Reunanen J, Meijerink M, et al. Pili-like proteins of Akkermansia muciniphila modulate host immune responses and gut barrier function[J]. PLoS One,2017, 12(3):e0173004.
Hua D X, Yang Q, Li X W, et al. The combination of Clostridium butyricum and Akkermansia muciniphila mitigates DSS-induced colitis and attenuates colitisassociated tumorigenesis by modulating gut microbiota and reducing CD8+T cells in mice[J]. m Systems, 2025,10(2):e01567-e01524.
Zhang T, Ji X H, Lu G C, et al. The potential of Akkermansia muciniphila in inflammatory bowel disease[J]. Appl Microbiol Biotechnol, 2021, 105(14):5785-5794.
Shuoker B, Pichler MJ, Jin C S, et al. Sialidases and fucosidases of Akkermansia muciniphila are crucial for growth on mucin and nutrient sharing with mucus-associated gut bacteria[J]. Nat Commun, 2023, 14(1):1833.
Jiang M S, Jia Y B, Ma C X, et al. Akkermansia muciniphila and its culture supernatant ameliorate colitis in interleukin-10 knockout mice via gut barrier and immune modulation[J]. Front Immunol, 2025, 16:1693007.
Kim S, Shin Y C, Kim T Y, et al. Mucin degrader Akkermansia muciniphila accelerates intestinal stem cellmediated epithelial development[J]. Gut Microbes, 2021,13(1):1892441.
Qu S, Zheng Y H, Huang Y C, et al. Excessive consumption of mucin by over-colonized Akkermansia muciniphila promotes intestinal barrier damage during malignant intestinal environment[J]. Front Microbiol,2023, 14:1111911.
Xiao M F, Zhang C, Duan H, et al. Cross-feeding of bifidobacteria promotes intestinal homeostasis:A lifelong perspective on the host health[J]. NPJ Biofilms Microbiomes, 2024, 10:47.
Kim J S, Kang S W, Lee J H, et al. The evolution and competitive strategies of Akkermansia muciniphila in gut[J]. Gut Microbes, 2022, 14(1):2025017.
Xu N, Xiao X P, Ma Y, et al. Advancements in understanding the relationship between Akkermansia muciniphila and the development of ulcerative colitis[J]. Front Pediatr, 2025, 13:1673156.
Parada Venegas D, De la Fuente M K, Landskron G, et al.Short chain fatty acids(SCFAs)-mediated gut epithelial and immune regulation and its relevance for inflammatory bowel diseases[J]. Front Immunol, 2019, 10:277.
Li Q M, Cui Y, Xu B C, et al. Main active components of Jiawei Gegen Qinlian decoction protects against ulcerative colitis under different dietary environments in a gut microbiota-dependent manner[J]. Pharmacol Res, 2021,170:105694.
Luo Y T, Fu S, Liu Y L, et al. Banxia Xiexin decoction modulates gut microbiota and gut microbiota metabolism to alleviate DSS-induced ulcerative colitis[J]. J Ethnopharmacol, 2024, 326:117990.
Lin H Y, Chen T F, Tsai T Y, et al. Banxia Xiexin Decoction prevents colitis by modulating gut microbiota and enhancing defensin and immunoglobulin A production[J]. Phytomedicine, 2025, 148:157393.
游丰锋,杨光勇,涂小华,等.保和丸对溃疡性结肠炎小鼠肠道内A. muciniphila菌的调节作用[J]. 光明中医, 2024, 39(2):237-240.
游丰锋,杨光勇,涂小华,等.保和丸对溃疡性结肠炎模型小鼠肠道益生菌A. muciniphila菌变化及肠黏膜屏障的影响[J]. 浙江中西医结合杂志, 2021, 31(4):303-307.
Xuan-Qing C H E N, Xiang-Yu L V, Shi-Jia L I U.Baitouweng decoction alleviates dextran sulfate sodiuminduced ulcerative colitis by regulating intestinal microbiota and the IL-6/STAT3 signaling pathway[J]. J Ethnopharmacol, 2021, 265:113357.
Wan Y, Yang L, Li H F, et al. Zingiber officinale and Panax ginseng ameliorate ulcerative colitis in mice via modulating gut microbiota and its metabolites[J]. J Chromatogr B Analyt Technol Biomed Life Sci, 2022,1203:123313.
Yuan Y L, Hu H R, Sun Z M, et al. Combining metagenomics, network pharmacology and RNA-seq strategies to reveal the therapeutic effects and mechanisms of Qingchang Wenzhong decoction on inflammatory bowel disease in mice[J]. Drug Des Devel Ther, 2024, 18:4273-4289.
邓鸿宇,向益,张旭朏,等.葛根芩连汤联合嗜黏蛋白阿克曼氏菌对溃疡性结肠炎小鼠的作用[J]. 内蒙古中医药, 2025, 44(12):107-110.
Zeng P J, Li J, Chen Y L, et al. The structures and biological functions of polysaccharides from traditional Chinese herbs[J]. Prog Mol Biol Transl Sci, 2019, 163:423-444.
肖瑞瑶,滕攀攀,綦世金,等.党参多糖对肠道微生态及肠道疾病作用研究进展[J]. 微生物学通报, 2023,50(2):687-696.
刘龙,顾忆,赵佳贺,等.党参多糖对嗜黏蛋白阿克曼菌生长代谢影响及其发酵液抗炎症性肠病机制预测[J]. 中国微生态学杂志, 2025, 37(3):282-293.
Zhou W T, Kan X H, Chen G J, et al. The polysaccharides from the fruits of Lycium barbarum L. modify the gut community profile and alleviate dextran sulfate sodiuminduced colitis in mice[J]. Int J Biol Macromol, 2022,222(Pt B):2244-2257.
Jing Y P, Li A P, Liu Z R, et al. Absorption of Codonopsis pilosula saponins by coexisting polysaccharides alleviates gut microbial dysbiosis with dextran sulfate sodiuminduced colitis in model mice[J]. Biomed Res Int, 2018,2018:1781036.
种莹,罗子宸,许伟辰,等.桔梗多糖对嗜黏蛋白阿克曼氏菌生长及代谢的影响[J]. 南京中医药大学学报,2023, 39(4):365-374.
Huo Z Q, Li J X, Li X F, et al. Functional fractions of Astragalus polysaccharides as a potential prebiotic to alleviate ulcerative colitis[J]. Int J Biol Macromol, 2024,271:132580.
李蓉,杨萍,李明鉴,等.发酵枸杞多糖通过调节肠道微生态缓解葡聚糖硫酸钠诱导的溃疡性结肠炎[J]. 中国药科大学学报, 2024, 55(2):236-245.
Feng W W, Liu J, Tan Y Z, et al. Polysaccharides from Atractylodes macrocephala Koidz. ameliorate ulcerative colitis via extensive modification of gut microbiota and host metabolism[J]. Food Res Int, 2020, 138(Pt B):109777.
Su L L, Mao C Q, Wang X C, et al. The anti-colitis effect of Schisandra chinensis polysaccharide is associated with the regulation of the composition and metabolism of gut microbiota[J]. Front Cell Infect Microbiol, 2020, 10:519479.
部繁.黄蜀葵花总黄酮依赖FXR调节“胆汁酸-肠道菌群”稳态改善DSS诱导小鼠结肠炎[D]. 南京:南京中医药大学, 2022.
Bu F, Ding Y, Chen T, et al. Total flavone of Abelmoschus manihot improves colitis by promoting the growth of Akkermansia in mice[J]. Sci Rep, 2021, 11(1):20787.
Huang G T, Wang Z N, Wu G X, et al. Lychee(Litchi chinensis Sonn.)pulp phenolics activate the short-chain fatty acid-free fatty acid receptor anti-inflammatory pathway by regulating microbiota and mitigate intestinal barrier damage in dextran sulfate sodium-induced colitis in mice[J]. J Agric Food Chem, 2021, 69(11):3326-3339.
Song X, Tan L, Wang M, et al. Myricetin:A review of the most recent research[J]. Biomed Pharmacother, 2021,134:111017.
Miao R R, Zhan S, Hu X T, et al. Myricetin and M10, a myricetin-3-O-β-d-lactose sodium salt, modify composition of gut microbiota in mice with ulcerative colitis[J]. Toxicol Lett, 2021, 346:7-15.
Dong S J, Zhu M, Wang K, et al. Dihydromyricetin improves DSS-induced colitis in mice via modulation of fecal-bacteria-related bile acid metabolism[J]. Pharmacol Res, 2021, 171:105767.
Zhou Y, Zheng J, Li Y, et al. Natural polyphenols for prevention and treatment of cancer[J]. Nutrients, 2016,8(8):515.
Alrafas H R, Busbee P B, Nagarkatti M, et al. Resveratrol modulates the gut microbiota to prevent murine colitis development through induction of Tregs and suppression of Th17 cells[J]. J Leukoc Biol, 2019, 106(2):467-480.
Li F, Han Y H, Cai X K, et al. Dietary resveratrol attenuated colitis and modulated gut microbiota in dextran sulfate sodium-treated mice[J]. Food Funct, 2020, 11(1):1063-1073.
Wang K, Yang Q Q, Ma Q X, et al. Protective effects of salvianolic acid a against dextran sodium sulfate-induced acute colitis in rats[J]. Nutrients, 2018, 10(6):791.
Wu X Y, Wang L J, Tang L, et al. Salvianolic acid B alters the gut microbiota and mitigates colitis severity and associated inflammation[J]. J Funct Foods, 2018, 46:312-319.
Wu Z H, Huang S M, Li T T, et al. Gut microbiota from green tea polyphenol-dosed mice improves intestinal epithelial homeostasis and ameliorates experimental colitis[J]. Microbiome, 2021, 9(1):184.
Zhang Z, Wu X Y, Cao S Y, et al. Caffeic acid ameliorates colitis in association with increased Akkermansia population in the gut microbiota of mice[J]. Oncotarget,2016, 7(22):31790-31799.
Zhang Z, Wu X Y, Cao S Y, et al. Chlorogenic acid ameliorates experimental colitis by promoting growth of Akkermansia in mice[J]. Nutrients, 2017, 9(7):677.
胡元利,谭晓梅,张文新.黄连总生物碱与盐酸小檗碱对小鼠溃疡性结肠炎治疗作用的比较[J]. 中药药理与临床, 2011, 27(5):45-48.
杨光勇,喻良锦,涂小华,等.黄连对溃疡性结肠炎小鼠肠道内嗜黏蛋白益生菌A. muciniphila菌及肠粘膜屏障的影响[J]. 中国民族民间医药, 2022, 31(5):27-32.
杨光勇,涂小华,游丰锋,等.基于q PCR技术分析黄连对溃疡性结肠炎小鼠肠道内嗜黏蛋白阿克曼氏菌的影响[J]. 中医药学报, 2021, 49(11):18-23.
Li C L, Deng L, Pu M, et al. Coptisine alleviates colitis through modulating gut microbiota and inhibiting TXNIP/NLRP3 inflammasome[J]. J Ethnopharmacol,2024, 335:118680.
Liao Z Q, Xie Y Z, Zhou B J, et al. Berberine ameliorates colonic damage accompanied with the modulation of dysfunctional bacteria and functions in ulcerative colitis rats[J]. Appl Microbiol Biotechnol, 2020, 104(4):1737-1749.
Li C, Yin X X, Xie C P, et al. Berberine attenuates TNBSinduced colitis in mice by improving the intestinal microbiota[J]. Front Microbiol, 2024, 15:1463005.
Lu Q, Wen X, Yang F, et al. Component characterization of Zanthoxylum nitidum extract and its anti-colitis effect through regulating PPARγ/NF-κB/iNOS signaling pathway and gut microbiota[J]. Int Immunopharmacol,2025, 162:115165.
Mao N N, Yu Y M, He J, et al. Matrine ameliorates DSSinduced colitis by suppressing inflammation, modulating oxidative stress and remodeling the gut microbiota[J]. Int J Mol Sci, 2024, 25(12):6613.
Cheng H, Liu J, Zhang D D, et al. Ginsenoside Rg1alleviates acute ulcerative colitis by modulating gut microbiota and microbial tryptophan metabolism[J]. Front Immunol, 2022, 13:817600.
Liu Y, Bai X, Wu H Y, et al. Ginsenoside CK alleviates DSS-induced IBD in mice by regulating tryptophan metabolism and activating aryl hydrocarbon receptor via gut microbiota modulation[J]. J Agric Food Chem, 2024,72(17):9867-9879.
Chen L, Chen M Y, Shao L, et al. Panax notoginseng saponins prevent colitis-associated colorectal cancer development:The role of gut microbiota[J]. Chin J Nat Med, 2020, 18(7):500-507.
Wang L, Shao L, Chen M Y, et al. Panax notoginseng alleviates colitis via the regulation of gut microbiota[J]. Am J Chin Med, 2023, 51(1):107-127.
Lin Z M, Chen L, Cheng M N, et al. Cortex periplocae modulates the gut microbiota to restrict colitis and colitisassociated colorectal cancer via suppression of pathogenic Th17 cells[J]. Biomed Pharmacother, 2022, 153:113399.

2026年第57卷第18期

PDF下载

引用本文

BibTeX

文章信息

doi: 10.7501/j.issn.0253-2670.2026.18.032

接收时间：2026-06-02
首发时间：2026-10-29

补充材料

相关文章

文章信息

作者

出版历史

收稿日期：2026-06-02

基金

作者信息

参考文献

分享链接

https://castjournals.cast.org.cn/joweb/zcy/CN/10.7501/j.issn.0253-2670.2026.18.032

分享至

全文二维码

扫描看全文

引用本文

BibTeX

本文的引用情况

2种不同金属材料的力学参数

科 Family	属数 Number of genus	种数 Number of species	占总种数比例 Percentage of total species (%)	属 Genus	种数 Number of species	占总种数比例 Percentage of total species (%)
鹅膏菌科Amanitaceae	2	11	5.26	鹅膏菌属 Amanita	10	4.78
小菇科 Mycenaceae	2	12	5.74	丝盖伞属 Inocybe	5	2.39
多孔菌科 Polyporaceae	8	14	6.70	蜡蘑属 Laccaria	5	2.39
红菇科 Russulaceae	3	23	11.00	小皮伞属 Marasmius	6	2.87
				小菇属 Mycena	11	5.26
				光柄菇属 Pluteus	5	2.39
				红菇属 Russula	17	8.13
				栓菌属 Trametes	5	2.39

关闭全屏

BibTeX
EndNote
RefWorks
TxT